A series of benzimidazole based thiadiazole and carbohydrazide conjugates have been synthesized and evaluated for inhibition of glycogen synthase kinase-3β and anti-depressant effect. Compounds 4f, 4j, 5b, 5g and 5i were found to be the most potent inhibitors of GSK-3β in vitro amongst the twenty-five benzimidazole based thiadiazole and carbohydrazide conjugates synthesized. Compound 5i was also found
已经合成了一系列基于
苯并咪唑的
噻二唑和碳酰
肼共轭物,并评估了其对
糖原合酶激酶-3β的抑制作用和抗抑郁作用。在合成的二十五种基于
苯并咪唑的
噻二唑和碳酰
肼共轭物中,发现化合物4f,4j,5b,5g和5i是体外最有效的GSK-3β
抑制剂。化合物5i当与已知的抗抑郁药
氟西汀相比时,
氟吡西汀还被发现在50 mg / kg的体内具有显着的抗抑郁活性。分子对接研究揭示了合成的化合物与多种
氨基酸残基(即GSK-3β上的ASP-133,LYS-183,PRO-136,VAL-135,TYR-134或LYS-60)的多个氢键相互作用。受体部位。